Bausch Health Companies BHC
NYSE BHC
$6.10 -0.06 (-0.97%)
As of: Sep 10, 2026 · 1:29 PM EDT

Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Share-based Compensation came in at $54.0 million in Q2 2026, up 17.39% year-over-year from $46.0 million in Q2 2025, and up 3.85% quarter-over-quarter from $52.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Share-based Compensation across 18 years of filings, most recently posting $54.0 million for Q2 2026.

  • In Q2 2026, Share-based Compensation rose 17.39% year-over-year to $54.0 million; the TTM figure through Jun 2026 stood at $233.0 million (up 37.06% YoY), while the FY2025 annual figure was $216.0 million, up 44.0% from the prior year.
  • Share-based Compensation came in at $54.0 million for Q2 2026 at Bausch Health Companies, up from $52.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $84.0 million in Q4 2025 to a low of $26.0 million in Q2 2022.
  • Average Share-based Compensation over 5 years is $40.6 million, with a median of $37.0 million recorded in 2024.
  • Year-over-year, Share-based Compensation decreased 21.95% in 2022 and soared 95.35% in 2025.
  • Over 5 years, Share-based Compensation stood at $35.0 million in 2022, then decreased by 17.14% to $29.0 million in 2023, then surged by 48.28% to $43.0 million in 2024, then jumped by 95.35% to $84.0 million in 2025, then sank by 35.71% to $54.0 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $54.0 million in Q2 2026, $52.0 million in Q1 2026, and $84.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Teva Pharmaceutical Industries 42.17 Bn 38.51 Bn 2.15 Bn 40.00 Mn
2 Viatris 18.99 Bn 18.10 Bn 1.46 Bn 30.40 Mn
3 Dr Reddys Laboratories 9.74 Bn 9.56 Bn 396.53 Mn 1.02 Mn
4 Amneal Pharmaceuticals 5.41 Bn 5.29 Bn 334.51 Mn 176,000.00
5 Bausch Health Companies 2.29 Bn 451.38 Mn 2.10 Bn 54.00 Mn
6 Alvotech 1.53 Bn 1.39 Bn 2.56 Mn 2.92 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 11.41 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 736.38 Mn 93.47 Mn 29.30 Mn
9 Fennec Pharmaceuticals 393.29 Mn 352.05 Mn 17.15 Mn 7.04 Mn
10 RedHill Biopharma 172.65 Mn 172.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.00 Mn
Mar 31, 2026 52.00 Mn
Dec 31, 2025 84.00 Mn
Sep 30, 2025 43.00 Mn
Jun 30, 2025 46.00 Mn
Mar 31, 2025 43.00 Mn
Dec 31, 2024 43.00 Mn
Sep 30, 2024 38.00 Mn
Jun 30, 2024 36.00 Mn
Mar 31, 2024 33.00 Mn
Dec 31, 2023 29.00 Mn
Sep 30, 2023 29.00 Mn
Jun 30, 2023 33.00 Mn
Mar 31, 2023 41.00 Mn
Dec 31, 2022 35.00 Mn
Sep 30, 2022 33.00 Mn
Jun 30, 2022 26.00 Mn
Mar 31, 2022 32.00 Mn
Dec 31, 2021 33.00 Mn
Sep 30, 2021 33.00 Mn